STOCK TITAN
  1. Home
  2. MMEDF

Mind Medicine (MindMed) (MMEDF) Stock Price, News & Analysis

MMEDF
Published by Stock Titan Data refreshed

What Changed

Company Description

This page collects what Stock Titan holds for MMEDF, including price data and latest news.

Stock Performance

Chart
$—
-
-
Last updated:
-
Performance 1 year
-
Market Cap
-
Shares outstanding

Latest News

View All
—

MindMed Announces Project Angie, Targeting the Treatment of Pain with Psychedelics

—

MindMed To Commence Trading on Nasdaq

—

MindMed Announces the Publication of New Data on Personalized MDMA Dosing

—

MindMed Announces Filing of Preliminary Base Shelf Prospectus and F-10 with the SEC under MJDS

—

MindMed Announces the Addition of Stanford University Neuroscientist as Chair of the Scientific Advisory Board

management
—

MindMed Announces Inclusion in FTSE Russell Indexes

—

MindMed Closes Acquisition of HealthMode, a Leading Machine Learning Digital Medicine Company

acquisition
—

MindMed Reaches Agreement to Acquire HealthMode, a Leading Machine Learning Digital Medicine Company

acquisition
—

MindMed's LSD Neutralizer Study Begins

—

MindMed Signs Partnership with Swiss Psychedelic Drug Discovery Startup MindShift Compounds AG, Expands Development Pipeline and IP Portfolio with Next-Gen Psychedelic and Empathogenic Compounds

partnership

Mind Medicine (MindMed) has 10 recent news articles. Key topics include management, acquisition, partnership. View all MMEDF news →

SEC Filings

View All

No SEC filings available for MMEDF.